AAPA

Introduction

The "You be the Judge" courtroom style CME symposium provides a unique audience interactive format for attendees to hear two faculty "counselors" (physician assistants) discuss the best approach to managing patients with type 2 diabetes mellitus (T2DM). Content provides a scientifically sound, fair and balanced overview of therapeutic options currently available or in development to manage patients with T2DM. The proceedings are moderated by "the judge" who will challenge the counselors to document their evidence-based statements and consider objections from the opposing counsel as well as the audience! In fact the audience at the symposium served as the "jury pool" and was asked to make a final jury verdict (via audience response system) at the completion of the symposium.

Are We Managing our Patients with Type 2 Diabetes Appropriately: You be the Judge!

Use icon in the bottom right hand corner of the video to view in full screen mode.

Powerpoint Slides

For your convenience, the powerpoint slides for this presentation may be downloaded by clicking here.

CME Credit

This program has been reviewed and is approved for 2.0 hours of AAPA Category I CME Credit. After viewing the webcast AAPA Fellow members may complete the post-test by clicking here. Expiration Date: August 2010.

Learning Objectives

At the conclusion of this symposium, participants will be able to:

1. Explain the progressive pathophysiology of T2DM and how this characteristic demands progressive therapeutic intervention to reach and maintain goals.
2. Explain the concept of the incretin effect, and describe defects in incretin secretion and incretin action that occur in type 2 diabetes.
3. List initial therapy options for diabetes and state the rationale for rapidly progressing to additional options as appropriate.
4. Discuss the pros and cons of incretin-based therapies and where they fit into the treatment algorithm.
5. Prepare patient case scenarios that follow treatment algorithms to motivate patients with diabetes to achieve their ADA guideline goals.

Faculty

Stephen Brunton, MD, FAAFP
Adjunct Clinical Professor
Department of Family Medicine
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina
Director of Faculty Development
Cabarrus Family Medicine Residency
Concord, North Carolina

Dwight M. Deter, PA-C, CDE
Clinical Assistant Professor
School of Allied Health Sciences, Physician Assistant Program
Texas Tech University Health Science Center
Southwest Endocrine Consultants
El Paso, Texas

B. Scott Urquhart, PA-C
Clinical Instructor
George Washington University School of Medicine and Health Sciences
Physician Assistant Program
Washington, D.C.
Adjunct Clinical Professor
James Madison University, Physician Assistant Program
Harrisonburg, Virginia
Diabetes and Thyroid Associates
Fredericksburg, Virginia

Faculty Disclosures

Dr. Brunton disclosed he is on the advisory boards for and has received honorarium from Amylin, Abbott Laboratories, Novo Nordisk, Inc. and Takeda Pharmaceuticals.

Mr. Deter disclosed he is on the speakers' bureaus for Bristol Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline and Sanofi-Aventis and has received honorarium from Bristol Myers Squibb, Daiichi-Sankyo, and Sanofi-Aventis.

Mr. Urquhart has no real or apparent conflicts of interest to report.

Statement of Commercial Support

This CME symposium is supported by an educational grant from Novo Nordisk Inc.